
Jul 28, 2026
Record Chinese biotech out-licensing meets rising US scrutiny
The rise of China's biotechnology sector has sparked significant concern in the United States, prompting a reassessment of policies regarding its growing global influence, as highlighted in a recent report by GlobalData.China's advancements in biotechnology are not only reshaping healthcare innovation but also have implications for pharmaceutical supply chains, economic competitiveness, and national security. According to Edita Hamzic, a healthcare analyst at GlobalData, the U.S. response is pri









